CAR-T therapy alters synthesis of platelet-activating factor in multiple myeloma patients

European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma

(2021) Benedetto Bruno et al.   HAEMATOLOGICA

HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA

(2021) Fengjie Jiang et al.   Journal of Hematology & Oncology

Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management

(2020) S. Vincent Rajkumar   AMERICAN JOURNAL OF HEMATOLOGY

Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives

(2019) Ronan Lordan et al.   MOLECULES

Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analog of PAF

(2018) Vyala Hanumanthareddy Chaithra et al.   JOURNAL OF LIPID RESEARCH

Phospholipid Remodeling in Physiology and Disease

(2018) Bo Wang et al.   Annual Review of Physiology

Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy

(2017) I A da Silva-Jr et al.   Oncogenesis

Involvement of platelets in tumor cell metastasis

(2016) Belay Tesfamariam   PHARMACOLOGY & THERAPEUTICS

Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis

(2015) Parwinder Gill et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Topical Photodynamic Therapy Induces Systemic Immunosuppression via Generation of Platelet-Activating Factor Receptor Ligands

(2015) Matheus Ferracini et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Glutamine inhibits platelet-activating factor-mediated pulmonary tumour metastasis

(2011) Han-A Kim et al.   EUROPEAN JOURNAL OF CANCER